aTyr Pharma reported $59.81M in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Ardelyx USD 587.52M 11.63M Sep/2026
aTyr Pharma USD 59.81M 10.02M Sep/2026
Biogen USD 32.05B 32.5M Sep/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Cipla INR 434.34B 9.38B Sep/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 138.36M 7.5M Jun/2026
CSL USD 37.9B 1.5B Dec/2025
Curis USD 29.69M 9.72M Mar/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Grifols EUR 23.15B 142.7M Dec/2025
Lakefront Biotherapeutics EUR 3.35B 21.24M Jun/2026
Novartis USD 117.15B 4.88B Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
United Therapeutics USD 7.03B 186M Sep/2026